| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0009 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.45 | 0.003 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.16 | 0.009 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |